Obstetrical and perinatal outcome in pregnant women with extrapulmonary tuberculosis [0.03%]
妊娠期肺外结核患者的产科及围生期结局
Vikas Yadav,J B Sharma,Garima Kachhawa et al.
Vikas Yadav et al.
Tuberculosis (TB) is a major health problem and a leading cause of illness and death from infectious disease. Tuberculosis in pregnancy has been associated with increased risks of prematurity and small for gestational age (SGA)infants.The p...
Identifying costs contributing to catastrophic expenditure among TB patients registered under RNTCP in Delhi metro city in India [0.03%]
印度国家结核病控制计划登记的结核病患者在首都地区发生灾难性支出的相关成本识别研究
Rohit Sarin,Vikram Vohra,Neeta Singla et al.
Rohit Sarin et al.
Background: Tuberculosis (TB) patients often incur large costs related to illness, as well as for seeking and receiving health care. Despite TB treatment being free under RNCTP, out of pocket expenditure incurred (OOP) by...
Tuberculosis and other chronic morbidity profile of sewage workers of Delhi [0.03%]
印度德里市下水道工人的肺结核和其他慢性病患病情况研究
Kalpana Chandra,Vijay Kumar Arora
Kalpana Chandra
Background: Sewage management is hazardous due to chronic exposure to chemical gases, bioaerosols and micro-organisms through inhalation; accidental oral intake and penetration through skin or mucous membranes through inj...
Observational Study
The Indian journal of tuberculosis. 2019 Jan;66(1):144-149. DOI:10.1016/j.ijtb.2018.09.003 2019
Pattern of missing probes in rifampicin resistant TB by Xpert MTB/RIF assay at a tertiary care centre in Mumbai [0.03%]
孟买三级医疗中心Xpert MTB / RIF检测利福平耐药结核病中缺失探针的模式
Swapna Kanade,Gita Nataraj,Preeti Mehta et al.
Swapna Kanade et al.
Setting: Department of Microbiology. Objective: To determine the common mutations responsible for rifampicin resistance in TB cases det...
Changes of CRP serum levels in pulmonary TB patients with AFB smear-positive sputum before and two months after receiving anti-tuberculosis drug treatment [0.03%]
涂阳肺结核患者抗结核治疗前后C-反应蛋白变化规律研究
Soedarsono Soedarsono,Mochamad Cahyo Subiantoro
Soedarsono Soedarsono
Background: Pulmonary tuberculosis (TB) produces an inflammatory process of the lung parenchyma. While effective treatment of pulmonary TB and disease resolution processes have an impact on decreasing inflammatory conditi...
Observational Study
The Indian journal of tuberculosis. 2019 Jan;66(1):134-138. DOI:10.1016/j.ijtb.2018.07.007 2019
Pharmacokinetics of rifabutin during atazanavir/ritonavir co-administration in HIV-infected TB patients [0.03%]
利福布丁联合阿扎那韦/利托那韦治疗艾滋病合并结核病患者的药动学研究
Geetha Ramachandran,A K Hemanth Kumar,T Kannan et al.
Geetha Ramachandran et al.
Background & objective: Rifabutin (RBT) is the rifamycin that is recommended to treat tuberculosis (TB) in HIV-infected individuals during combination antiretroviral therapy (ART) containing HIV protease inhibitors (PIs)....
Socio-demographic profile and treatment outcomes in pediatric TB patients attending DOTS centers in urban areas of Delhi [0.03%]
德里城市地区DOTS门诊就诊的儿童结核病患者的流行病学和社会人口学特征及治疗效果
S Dhaked,N Sharma,K K Chopra et al.
S Dhaked et al.
Background: India accounts for one fourth of the global tuberculosis (TB) burden. In 2015, an estimated 28 lakh cases occurred and 4.8 lakh people died due to TB and proportion of children among new TB patients was 6% in ...
Mahesh S Vasava,Sneha G Nair,Sanjay K Rathwa et al.
Mahesh S Vasava et al.
Tuberculosis (TB) being the leading infectious killer in the domain wherein globally, almost 20% of all TB strains are resistant to at least 1 major TB drug and there's a growing incidence of multi-drug resistance tuberculosis (MDR-TB). Loo...
A prospective study on quality of life in patients with pulmonary tuberculosis at a tertiary care hospital in Kashmir, Northern India [0.03%]
印度北部克什米尔地区三级医疗机构肺结核患者生活质量前瞻性研究
Shabir Ahmad Dar,Naveed Nazir Shah,Zaid Ahmad Wani et al.
Shabir Ahmad Dar et al.
Background: Pulmonary Tuberculosis (PTB) is a contagious, airborne infection that destroys when M. tuberculosis primarily attacks the lungs. PTB is curable with an early diagnosis and antibiotic treatment. Stigmatization ...
Efficacy and safety of cholecalciferol-augmented anti-tuberculosis therapy for treatment of naïve patients with pulmonary tuberculosis: A randomized, controlled, clinical study [0.03%]
维生素D联合标准化疗方案治疗初治肺结核患者的疗效和安全性：随机对照临床试验
Ahmad Farooq Alsayed Hasanain,Ali Abdel-Azeem Hasan Zayed,Rasha Bakheet Abd-Ellatief et al.
Ahmad Farooq Alsayed Hasanain et al.
Background/objective: Vitamin D deficiency may contribute to the therapeutic failure of antituberculosis therapy (ATT). The aim of this study is to explore the role of adding cholecalciferol to the standard ATT in improvi...
Randomized Controlled Trial
The Indian journal of tuberculosis. 2019 Jan;66(1):111-117. DOI:10.1016/j.ijtb.2018.06.004 2019